Cyclin D1 Repression of Peroxisome Proliferator-activated Receptor Gamma Expression and Transactivation

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 2003 Aug 15

PMID 12917338

Citations 92

Authors

Chenguang Wang

Nagarajan Pattabiraman

Jian Nian Zhou

Maofu Fu

Toshiyuki Sakamaki

Chris Albanese

Zhiping Li

Kongming Wu

James Hulit

Peter Neumeister

Phyllis M Novikoff

Michael Brownlee

Philipp E Scherer

Joan G Jones

Kathleen D Whitney

Lawrence A Donehower

Emily L Harris

Thomas Rohan

David C Johns

Richard G Pestell

Affiliations

Soon will be listed here.

Abstract

The cyclin D1 gene is overexpressed in human breast cancers and is required for oncogene-induced tumorigenesis. Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a nuclear receptor selectively activated by ligands of the thiazolidinedione class. PPAR gamma induces hepatic steatosis, and liganded PPAR gamma promotes adipocyte differentiation. Herein, cyclin D1 inhibited ligand-induced PPAR gamma function, transactivation, expression, and promoter activity. PPAR gamma transactivation induced by the ligand BRL49653 was inhibited by cyclin D1 through a pRB- and cdk-independent mechanism, requiring a region predicted to form an helix-loop-helix (HLH) structure. The cyclin D1 HLH region was also required for repression of the PPAR gamma ligand-binding domain linked to a heterologous DNA binding domain. Adipocyte differentiation by PPAR gamma-specific ligands (BRL49653, troglitazone) was enhanced in cyclin D1(-/-) fibroblasts and reversed by retroviral expression of cyclin D1. Homozygous deletion of the cyclin D1 gene, enhanced expression by PPAR gamma ligands of PPAR gamma and PPAR gamma-responsive genes, and cyclin D1(-/-) mice exhibit hepatic steatosis. Finally, reduction of cyclin D1 abundance in vivo using ponasterone-inducible cyclin D1 antisense transgenic mice, increased expression of PPAR gamma in vivo. The inhibition of PPAR gamma function by cyclin D1 is a new mechanism of signal transduction cross talk between PPAR gamma ligands and mitogenic signals that induce cyclin D1.

Citing Articles

A cyclin D1 intrinsically disordered domain accesses modified histone motifs to govern gene transcription.

Jiao X, Di Sante G, Casimiro M, Tantos A, Ashton A, Li Z Oncogenesis. 2024; 13(1):4.

PMID: 38191593 PMC: 10774418. DOI: 10.1038/s41389-023-00502-1.

Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.

Lee J, Song J, Park J, Chung M, Lee S, Jeon S Exp Mol Med. 2023; 55(1):143-157.

PMID: 36609599 PMC: 9898513. DOI: 10.1038/s12276-022-00919-5.

Inhibiting DNA methylation as a strategy to enhance adipose-derived stem cells differentiation: Focus on the role of Akt/mTOR and Wnt/β-catenin pathways on adipogenesis.

Ceccarelli S, Gerini G, Megiorni F, Pontecorvi P, Messina E, Camero S Front Cell Dev Biol. 2022; 10:926180.

PMID: 36120582 PMC: 9478209. DOI: 10.3389/fcell.2022.926180.

The SREBP-dependent regulation of cyclin D1 coordinates cell proliferation and lipid synthesis.

Aldaalis A, Bengoechea-Alonso M, Ericsson J Front Oncol. 2022; 12:942386.

PMID: 36091143 PMC: 9451027. DOI: 10.3389/fonc.2022.942386.

Mammalian adipogenesis regulator (Areg) cells use retinoic acid signalling to be non- and anti-adipogenic in age-dependent manner.

Zachara M, Rainer P, Hashimi H, Russeil J, Alpern D, Ferrero R EMBO J. 2022; 41(18):e108206.

PMID: 35996853 PMC: 9475530. DOI: 10.15252/embj.2021108206.

References

Westwick J, Lambert Q, Clark G, Symons M, Van Aelst L, Pestell R . Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways. Mol Cell Biol. 1997; 17(3):1324-35. PMC: 231857. DOI: 10.1128/MCB.17.3.1324. View

Zwijsen R, Wientjens E, Klompmaker R, van der Sman J, Bernards R, Michalides R . CDK-independent activation of estrogen receptor by cyclin D1. Cell. 1997; 88(3):405-15. DOI: 10.1016/s0092-8674(00)81879-6. View

Xu H, Lambert M, Montana V, Plunket K, Moore L, Collins J . Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors. Proc Natl Acad Sci U S A. 2001; 98(24):13919-24. PMC: 61142. DOI: 10.1073/pnas.241410198. View

Davies G, McFie P, Khandelwal R, Roesler W . Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-gamma expression in hepatocytes. J Pharmacol Exp Ther. 2001; 300(1):72-7. DOI: 10.1124/jpet.300.1.72. View

Rosen E, Hsu C, Wang X, Sakai S, Freeman M, Gonzalez F . C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev. 2002; 16(1):22-6. PMC: 155311. DOI: 10.1101/gad.948702. View

Xu H, Stanley T, Montana V, Lambert M, Shearer B, Cobb J . Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature. 2002; 415(6873):813-7. DOI: 10.1038/415813a. View

Combs T, Wagner J, Berger J, Doebber T, Wang W, Zhang B . Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology. 2002; 143(3):998-1007. DOI: 10.1210/endo.143.3.8662. View

Chalandon Y, Jiang X, Hazlewood G, Loutet S, Conneally E, Eaves A . Modulation of p210(BCR-ABL) activity in transduced primary human hematopoietic cells controls lineage programming. Blood. 2002; 99(9):3197-204. DOI: 10.1182/blood.v99.9.3197. View

Yu S, Matsusue K, Kashireddy P, Cao W, Yeldandi V, Yeldandi A . Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem. 2002; 278(1):498-505. DOI: 10.1074/jbc.M210062200. View

10.

Albanese C, Wu K, DAmico M, Jarrett C, Joyce D, Hughes J . IKKalpha regulates mitogenic signaling through transcriptional induction of cyclin D1 via Tcf. Mol Biol Cell. 2003; 14(2):585-99. PMC: 149994. DOI: 10.1091/mbc.02-06-0101. View

11.

Novikoff P, NOVIKOFF A . Peroxisomes in absorptive cells of mammalian small intestine. J Cell Biol. 1972; 53(2):532-60. PMC: 2108721. DOI: 10.1083/jcb.53.2.532. View

12.

NOVIKOFF A, Novikoff P, Davis C, Quintana N . Studies on microperoxisomes. II. A cytochemical method for light and electron microscopy. J Histochem Cytochem. 1972; 20(12):1006-23. DOI: 10.1177/20.12.1006. View

13.

Novikoff P, Yam A . Sites of lipoprotein particles in normal rat hepatocytes. J Cell Biol. 1978; 76(1):1-11. PMC: 2109971. DOI: 10.1083/jcb.76.1.1. View

14.

Wang T, Cardiff R, Zukerberg L, Lees E, Arnold A, SCHMIDT E . Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 1994; 369(6482):669-71. DOI: 10.1038/369669a0. View

15.

Tontonoz P, Hu E, Spiegelman B . Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell. 1994; 79(7):1147-56. DOI: 10.1016/0092-8674(94)90006-x. View

16.

Weinberg R . The retinoblastoma protein and cell cycle control. Cell. 1995; 81(3):323-30. DOI: 10.1016/0092-8674(95)90385-2. View

17.

Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A . Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem. 1995; 270(40):23589-97. DOI: 10.1074/jbc.270.40.23589. View

18.

Wu Z, Xie Y, BUCHER N, Farmer S . Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev. 1995; 9(19):2350-63. DOI: 10.1101/gad.9.19.2350. View

19.

Zwijsen R, Klompmaker R, Wientjens E, Kristel P, van der Burg B, Michalides R . Cyclin D1 triggers autonomous growth of breast cancer cells by governing cell cycle exit. Mol Cell Biol. 1996; 16(6):2554-60. PMC: 231245. DOI: 10.1128/MCB.16.6.2554. View

20.

Neuman E, Ladha M, Lin N, Upton T, Miller S, DiRenzo J . Cyclin D1 stimulation of estrogen receptor transcriptional activity independent of cdk4. Mol Cell Biol. 1997; 17(9):5338-47. PMC: 232384. DOI: 10.1128/MCB.17.9.5338. View